BWXT Medical submits Tc-99m generator application to FDA

September 14, 2022, 3:02PMNuclear News

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.

To continue reading, log in or create a free account!

Related Articles

BWXT Canada awarded major contracts for 2 OPG plants

Work will support Pickering life extension and Darlington SMRs

January 29, 2025, 9:30AMNuclear News

Ontario Power Generation announced this week new contracts with BWXT Canada worth more than C$1 billion ($695.4 million) for projects at the Pickering and Darlington nuclear power plants....